Skip to content

Rechercher des études

Résultats de recherche

The purpose of this study is to compare how effective and how tolerable two different bowel preparation laxatives are for colonoscopy. The aim is to compare oral sulfate solution (OSS) to another laxative called 2L polyethylene glycol (PEG) solution to see which is more effective and more tolerable by individuals with IBD (Crohn's disease or Ulcerative colitis).

Conditions:
Crohn Disease | Ulcerative Colitis
Emplacement:
  • University of Manitoba, Winnipeg, Manitoba, Canada
Sexe:
ALL
Âges:
Over 18

The goal of this clinical trial is to test the impact inhalers have on blood vessels in young healthy individuals. The main question it aims to answer is if long term use of asthma inhalers have any effect on the blood vessels and heart. Participants will be asked to: * Perform lung function and exercise tests * Have ultrasound images taken of the artery in their arm * Use an inhaler for 4 weeks * Visit the lab for testing on 4-6 different occasions Researchers will compare two different inhalers (Ventolin and Symbicort) with a placebo to see if the inhalers have any effect on the blood vessels over the 4 week period.

Conditions:
Healthy
Emplacement:
  • Clinical Physiology Laboratory, Edmonton, Alberta, Canada
Sexe:
ALL
Âges:
18 - 40

The objective is to study in a prospective, interventional, single arm, cohort study the potential synergistic diuretic effect of empagliflozin, in addition to furosemide, in hypervolemic patients admitted with acutely decompensated heart failure and diuretic resistance at the McGill University Health Centre (MUHC). The investigators hypothesize that the sodium-glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin will enhance the diuretic effect of furosemide in patients with acutely decompensated heart failure, moderate to advanced chronic kidney disease, and underlying diuretic resistance, as identified by the three-hour urine output post diuretic administration on the first day of the study, compared with furosemide alone.

Conditions:
Acute Heart Failure | Chronic Kidney Diseases
Emplacement:
  • Research Institute of the McGill University Health Center, Montreal, Quebec, Canada
Sexe:
ALL
Âges:
Over 18

This study investigates how orally ingested exogenous ketone monoester supplements affect circulating hormone concentrations in healthy young adult males after a single session of resistance exercise. Resistance exercise is known to stimulate an acute increase in the circulating concentration of various hormones that are involved in the regulation of muscle mass, including testosterone, growth hormone (GH), and insulin-like growth factor-1 (IGF-1). Recently, there has been growing interest in how nutritional supplements impact these natural hormone responses at rest. One such intervention is the oral ingestion of exogenous ketone body supplements. Ketone bodies (i.e., β-hydroxybutyrate (β-HB), acetoacetate (AcAc), and acetone) are naturally occurring compounds that are normally produced by the body during prolonged fasting/starvation, or in response to a "ketogenic" diet (a diet very high in fat and very low in carbohydrates). These ketone body supplements taken in the form of a ketone monoester can quickly raise blood ketone levels without needing to change your diet. Recent research has shown that the ingestion of exogenous ketone supplements or following a 'ketogenic diet' can alter the concentration of certain hormones measured in blood samples at rest. However, the effects of ketone monoester intake on the exercise-induced elevation in circulating hormones is yet to be explored. Therefore, the purpose of this study is to examine how elevated β-HB, induced via the ingestion of the ketone monoester (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate, affects blood concentrations of various anabolic hormones, during post-exercise recovery in healthy young adult males, compared to a placebo drink (flavoured water).

Conditions:
Ketosis | Resistance Exercise | Testing Effect of Intervention | Ketone Body | Blood Hormones
Emplacement:
  • McGill University, Montreal, Quebec, Canada
Sexe:
MALE
Âges:
18 - 40

To investigate the influence of early therapeutic drug monitoring and dose optimization on disease outcome in Crohn's patients treated with Adalimumab.

Conditions:
Inflammatory Bowel Diseases | Crohn Disease | Drug Monitoring
Emplacement:
  • Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke, Quebec, Canada
  • The University of British Columbia, Vancouver, British Columbia, Canada
  • University of Calgary Medical Center (UCMC), Calgary, Alberta, Canada
  • McGill University Hospital Center (MUHC), Montréal, Quebec, Canada
  • London Health Sciences Centre (LHSC) University Hospital, London, Ontario, Canada
  • The Ottawa Hospital, IBD Centre of Excellence, Ottawa, Ontario, Canada
Sexe:
ALL
Âges:
Over 18

This prospective, global, multicenter, single arm post-approval study is designed to investigate the clinical use and safety of the Lutonix® 035 AV Drug Coated Balloon (DCB) PTA Catheter in subjects presenting with clinical and hemodynamic abnormalities in native arteriovenous (AV) fistulae located in the upper extremity.

Conditions:
Arteriovenous Fistula
Emplacement:
  • Centre hospitalier de l'Université de Montreal, Montréal, Quebec, Canada
  • University Health Network, Toronto, Ontario, Canada
  • William Osler Health System/Brampton Civic Hospital, Brampton, Ontario, Canada
  • Scarborough Health Network, Scarborough, Ontario, Canada
Sexe:
ALL
Âges:
Over 18

The purpose of this study is to find out if there are any patterns in the way people's bodies react to physical activities and their voices when they have heart failure, a disease where the heart cannot function sufficiently. To do this, the investigators will use a smartwatch that can measure multiple signals like the participant's heart rate and movement. Investigators will ask participants with and without heart failure to wear the Watch HOP (from HOP-Child Technologies Inc.) and sensors during physical tasks at their clinic visit at the McGill University Health Centre. Researchers will also record the participants' voices between their visits. The key signals can help find who is at risk for heart failure or develop new ways to monitor and treat it.

Conditions:
Heart Failure
Emplacement:
  • McGill University Health Centre, Montreal, Quebec, Canada
Sexe:
ALL
Âges:
Over 18

One significant challenge to non-invasive ventilation (NIV) use in children is finding masks to fit a wide range of growing shapes and sizes. While the technology has improved with development of masks specifically for children, the range of options remains limited. Given the smaller size relative to adults, craniofacial abnormalities and craniofacial differences are more likely to compromise mask fit for children. A poor mask fit is uncomfortable, alters delivery of airway pressure, and, in some children, leads to failure of NIV and the need for surgical insertion of an airway in the neck to deliver positive airway pressure through a tracheostomy. This makes expanding the technology to deliver NIV vital and custom NIV masks an exciting solution.In this study, this study will enroll children who are established on long-term NIV with at least some use within 3 months of starting this therapy but who have non-optimal adherence. After consenting to participate and completing demographic and health questionnaire, participants will undergo a facial scan using stereophotogrammetry. This scan will be imported into a computer-aided design software to create a NIV mask customized to the individual face. The steps of mask testing will include: i) Bench testing to compare the leak and comfort parameters of the current commercial mask used by the participant to the custom mask: ii) Efficacy of treatment as measured by polysomonography iii) NIV compliance from machine downloads; iv) Questionnaires to assess the subjective comfort, fit, and adverse events Finally, participants and their parents/guardian will be asked which mask they prefer and why.

Conditions:
Adherence, Patient | Child, Only | Noninvasive Ventilation
Emplacement:
  • University of Alberta, Edmonton, Alberta, Canada
Sexe:
ALL
Âges:
8 - 12

This study will examine the effectiveness of the PelvicSense 3-month online program on pain and other outcomes in those with provoked vestibulodynia. This study is prospective in nature and will involve several assessment points: baseline, immediately post-treatment (at the end of the 3 month program), and 3-month follow up. All aspects of the study will be conducted remotely (e.g., online, email, video calls), and participants will be at least 18 years of age, fluent in English, and experience pain due to provoked vestibulodynia for at least 3 months with a physician diagnosis. Participants are expected to continue their treatment as usual and this information will be documented throughout the study.

Conditions:
Provoked Vestibulodynia
Emplacement:
  • Sexual Health Research Laboratory, Department of Psychology, Queen's University, Kingston, Ontario, Canada
Sexe:
FEMALE
Âges:
Over 18

The Neonatal Resuscitation Program (NRP) recommends providers renew their certification every 2 years. However, many Neonatal Intensive Care Units (NICUs) in Canada face challenges of significant budget cuts in training and a large number of caregivers to train with a high turnover rate. This situation makes it difficult for managers and nurse educators to ensure up-to-date certification and competence for all clinical staff. In addition, considering that only 0.1% of newborns will require cardiac massage and/or epinephrine, health care professionals' exposure to critical events is low to insure maintenance of expertise. Furthermore, it is shown that there is a significant decrease in knowledge among learners who have undergone specific training after only 3 months. This is worrisome considering that some nurses will not renew their certification if the course is not paid for by the employer, or if they are not released from clinical duties to attend. While keeping in mind the various required components of NRP training: book reading, online exam, performance stations, Integrated Skills Station Assessment (ISSA) and simulations, we would like to assess the educational and financial impact of a new educational strategy developed as to allow more nurses to be retrained thus ensuring maintenance of their neonatal resuscitation expertise.

Conditions:
Nurse Training in Neonatal Resuscitation
Emplacement:
  • University of Montreal Health Center, Montreal, Quebec, Canada
  • Cité de la santé de Laval, Laval, Quebec, Canada
  • Université de Sherbrooke, Sherbrooke, Quebec, Canada
  • CHU Sainte-Justine, Dept Neonatology, Montréal, Quebec, Canada
  • CHUL, Québec, Quebec, Canada
Sexe:
ALL
Âges:
Over 18